Document is current
Any future updates will be listed below
-
Authors
McGeachan, Robert I. https://orcid.org/0000-0003-1647-8642
Keavey, Lois
Simzer, Elizabeth M.
Chang, Ya Yin https://orcid.org/0000-0001-9794-403X
Rose, Jamie L.
Spires-Jones, Maxwell P.
Gilmore, Mollie
Holt, Kristjan https://orcid.org/0000-0003-3903-6361
Meftah, Soraya https://orcid.org/0000-0002-3408-5626
Ravingerova, Natalia
Scutariu, Cristina
Taylor, Lewis W.
King, Declan
Tzioras, Makis https://orcid.org/0000-0002-2660-5943
Tulloch, Jane https://orcid.org/0009-0005-6975-5430
Booker, Sam A. https://orcid.org/0000-0003-1980-9873
Liaquat, Imran
Hindley-Pollock, Nicole
Geary, Bethany
Smith, Colin
Brennan, Paul M. https://orcid.org/0000-0002-7347-830X
Durrant, Claire S. https://orcid.org/0000-0001-7552-7358
Spires-Jones, Tara L. https://orcid.org/0000-0003-2530-0598
-
Funding
Funding for this research was provided by:
Alzheimer's Research UK (ARUK-EG2016A-6; ARUK-PhD2023-002, ARUK-PhD2023-002)
UK Dementia Research Institute
Wellcome Trust (225442/Z/22/Z)
Dyson Foundation
- License Information
-
More Information
Article History
Received: 9 February 2024
Accepted: 7 May 2025
First Online: 16 July 2025
Competing interests
: T.L.S.-J. is a scientific advisory board member of Scottish Brain Sciences, Cognition Therapeutics and Race Against Dementia, and has received consulting fees or honoraria from Jay Therapeutics, Sanofi, AbbVie, Merck and Eisai. M.T. is an employee of Scottish Brain Sciences. The other authors declare no competing interests.
